Castle biosciences reports second quarter 2023 results

Friendswood, texas--(business wire)---- $cstl #earnings--castle biosciences, inc. (nasdaq: cstl), a company improving health through innovative tests that guide patient care, today announced its financial results for the second quarter and six months ended june 30, 2023. “castle delivered an outstanding second quarter, with strength across our entire test portfolio,” said derek maetzold, president and chief executive officer of castle biosciences. “building on our first quarter momentum and driven by consistent ex.
CSTL Ratings Summary
CSTL Quant Ranking